Literature DB >> 8115152

Relation between lens opacities and vitamin and mineral supplement use.

J A Mares-Perlman1, B E Klein, R Klein, L L Ritter.   

Abstract

PURPOSE: The authors evaluated the cross-sectional and longitudinal relations between lens opacities and intake of vitamins and minerals in supplements.
METHODS: Type and quantity of vitamins and minerals taken currently and 10 years before interview were obtained in a population-based sample of persons in the Nutritional Factors in Eye Disease Study (n = 2152).
RESULTS: In persons without diabetes, regular use of multivitamin preparations 10 years in the past was associated with decreased risk for nuclear sclerosis (odds ratio [OR], 0.6; 95% confidence interval [CI], 0.5, 0.8) and increased the risk for cortical opacities (OR, 1.6; CI, 1.1, 2.2). In persons with diabetes, past multivitamin use was not associated with nuclear sclerosis (OR, 1.1; CI, 0.4,2.7) but with decreased risk for cortical opacities (OR, 0.1; CI, 0.0, 0.9). Cross-sectional associations with current intake of supplements were weaker, but in the same direction. Multivitamin use was not cross-sectionally or longitudinally related to posterior subcapsular cataract in persons with or without diabetes.
CONCLUSION: Use of vitamin supplements is longitudinally associated with nuclear and cortical opacities. However, the direction of the association is influenced by the type of opacity and diabetes status.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8115152     DOI: 10.1016/s0161-6420(94)31333-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

Review 1.  Management of cataract.

Authors:  R Dickson; A Eastwood; P Gill; A Melville; S O'Meara; T Sheldon
Journal:  Qual Health Care       Date:  1996-09

Review 2.  Lifestyle exposures and eye diseases in adults.

Authors:  Barbara E K Klein; Ronald Klein
Journal:  Am J Ophthalmol       Date:  2007-10-18       Impact factor: 5.258

3.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-10

Review 4.  Cigarettes and cataract: cadmium or a lack of vitamin C?

Authors:  J J Harding
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

5.  The Relationship Between Serum 25-Hydroxyvitamin D Levels and Nuclear Cataract in the Carotenoid Age-Related Eye Study (CAREDS), an Ancillary Study of the Women's Health Initiative.

Authors:  Prethy Rao; Amy E Millen; Kristin J Meyers; Zhe Liu; Rickie Voland; Sheri Sondel; Lesley Tinker; Robert B Wallace; Barbara A Blodi; Neil Binkley; Gloria Sarto; Jennifer Robinson; Erin LeBlanc; Julie A Mares
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

Review 6.  Can drugs or micronutrients prevent cataract?

Authors:  J J Harding
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

7.  Prospective study showing that dietary vitamin C reduced the risk of age-related cataracts in a middle-aged Japanese population.

Authors:  Masao Yoshida; Yutaka Takashima; Manami Inoue; Motoki Iwasaki; Tetsuya Otani; Satoshi Sasaki; Shoichiro Tsugane
Journal:  Eur J Nutr       Date:  2007-03       Impact factor: 5.614

Review 8.  Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract.

Authors:  Milan C Mathew; Ann-Margret Ervin; Jeremiah Tao; Richard M Davis
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

Review 9.  [Antioxidative vitamins and cataracts in the elderly].

Authors:  H Heseker
Journal:  Z Ernahrungswiss       Date:  1995-09

10.  The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India.

Authors:  D C Gritz; M Srinivasan; S D Smith; U Kim; T M Lietman; J H Wilkins; B Priyadharshini; R K John; S Aravind; N V Prajna; R Duraisami Thulasiraj; J P Whitcher
Journal:  Br J Ophthalmol       Date:  2006-03-23       Impact factor: 4.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.